NKTX
Price
$1.84
Change
+$0.01 (+0.54%)
Updated
Apr 1, 04:59 PM (EDT)
Capitalization
130.56M
36 days until earnings call
SLNO
Price
$68.26
Change
-$3.19 (-4.46%)
Updated
Apr 1 closing price
Capitalization
3.13B
41 days until earnings call
Ad is loading...

NKTX vs SLNO

Header iconNKTX vs SLNO Comparison
Open Charts NKTX vs SLNOBanner chart's image
Nkarta
Price$1.84
Change+$0.01 (+0.54%)
Volume$19.19K
Capitalization130.56M
Soleno Therapeutics
Price$68.26
Change-$3.19 (-4.46%)
Volume$1.9M
Capitalization3.13B
NKTX vs SLNO Comparison Chart
Loading...
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NKTX vs. SLNO commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NKTX is a Buy and SLNO is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (NKTX: $1.84 vs. SLNO: $71.45)
Brand notoriety: NKTX and SLNO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NKTX: 118% vs. SLNO: 361%
Market capitalization -- NKTX: $130.56M vs. SLNO: $3.13B
NKTX [@Biotechnology] is valued at $130.56M. SLNO’s [@Biotechnology] market capitalization is $3.13B. The market cap for tickers in the [@Biotechnology] industry ranges from $302.51B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NKTX’s FA Score shows that 1 FA rating(s) are green whileSLNO’s FA Score has 0 green FA rating(s).

  • NKTX’s FA Score: 1 green, 4 red.
  • SLNO’s FA Score: 0 green, 5 red.
According to our system of comparison, both NKTX and SLNO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NKTX’s TA Score shows that 5 TA indicator(s) are bullish while SLNO’s TA Score has 6 bullish TA indicator(s).

  • NKTX’s TA Score: 5 bullish, 4 bearish.
  • SLNO’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, NKTX is a better buy in the short-term than SLNO.

Price Growth

NKTX (@Biotechnology) experienced а +18.71% price change this week, while SLNO (@Biotechnology) price change was +42.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.07%. For the same industry, the average monthly price growth was -13.26%, and the average quarterly price growth was -12.25%.

Reported Earning Dates

NKTX is expected to report earnings on May 08, 2025.

SLNO is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-9.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLNO($3.13B) has a higher market cap than NKTX($131M). SLNO YTD gains are higher at: 58.954 vs. NKTX (-26.104). NKTX has higher annual earnings (EBITDA): -119.34M vs. SLNO (-173.63M). SLNO (291M) and NKTX (283M) have equal amount of cash in the bank . SLNO has less debt than NKTX: SLNO (52.8M) vs NKTX (85.4M). NKTX (0) and SLNO (0) have equivalent revenues.
NKTXSLNONKTX / SLNO
Capitalization131M3.13B4%
EBITDA-119.34M-173.63M69%
Gain YTD-26.10458.954-44%
P/E RatioN/AN/A-
Revenue00-
Total Cash283M291M97%
Total Debt85.4M52.8M162%
FUNDAMENTALS RATINGS
SLNO: Fundamental Ratings
SLNO
OUTLOOK RATING
1..100
26
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
65
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NKTXSLNO
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 5 days ago
86%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CWMEX60.810.43
+0.71%
American Funds Washington Mutual 529E
ACBYX14.850.06
+0.41%
American Beacon Balanced Y
JSECX18.750.06
+0.32%
JPMorgan Small Cap Equity C
CAMWX27.14N/A
N/A
Cambiar Opportunity Inst
OAKGX34.04-0.12
-0.35%
Oakmark Global Investor

NKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTX has been loosely correlated with FATE. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTX jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTX
1D Price
Change %
NKTX100%
-8.00%
FATE - NKTX
51%
Loosely correlated
-6.97%
BEAM - NKTX
48%
Loosely correlated
-12.07%
IPSC - NKTX
46%
Loosely correlated
-7.19%
ALLO - NKTX
45%
Loosely correlated
-5.81%
CRBU - NKTX
44%
Loosely correlated
-2.77%
More